What do people think of CW ?
Some of these attributes don't speak positively about what he can do for shareholders . He seems more like a career CEO ?
1. Ernst & Young Award
2. "I have a dream speech"
3. The Copaxone stock options incentives he awarded to himself for launching in 2014
4. The usual generality that is spewed in every conference call. No specifics, No timelines, No idea how much it costs to characterize 1 biologic (is it 30m, 50m or 100m)No specific future goals with timelines, No plan for the 400M bank balance (other than we are running business conservatively - 2014 copaxone launch)...Really are you going to burn 300m bank balance in 3 years ?? For what ??? What are they going to launch by burning 400 or 300m in next 3 years- they better launch something? I see nothing in their pipe other than copaxone that they can launch in 3 years
wheeler and this management team can learn a thing or two from this company's management
1. communication to shareholders
2. sense of urgency
3. putting specific goals and exceeding expectations
The ONLY to make CW accountable(to maximize shareholder value) is hint MNTA's value to this talented guy
"At the same time, we are providing patients with more affordable medicine, which is a very rewarding aspect of our business."
Brother, we can all philosophize later.
whats your milestone timeline, plan & progress for FOB ? whats your milestone timeline, plan and progress for new drugs ? what's your plan for cash ? does it make sense to deploy that cash for generating value for shareholders ?
<< whats your milestone timeline, plan & progress for FOB ? whats your milestone timeline, plan and progress for new drugs ? what's your plan for cash ? does it make sense to deploy that cash for generating value for shareholders ? >> Do you do anything but ask questions? You should be an attorney, but on second thought your questions are a waste of the courts time so either get on with it or I'm going to dismiss this case based on the grounds of complete stupidity.
<< What do people think of investorgold ? >> He's from Troy, MI, and after reading a couple of his posts its obvious he has no clue.
<< What are they going to launch by burning 400 or 300m in next 3 years- they better launch something? I see nothing in their pipe other than copaxone that they can launch in 3 years >>
Are you stupid or something? Only a fool would think MNTA would burn through $400M while generating an additional $200M per year. They better launch something? Haha, they better? Because generating $200+M in ATFCF annually isn't enough? Oh and way to completely discount Copaxone (a $700M - 1 billion opportunity). MNTA could receive approval anytime and be on the market the next day but who cares about that for a company with less than a $1B market cap, $350M in cash and a $1.5B drug approved and generating $200M in ATFCF. You clearly have no idea what you're talking about.
BTW, FoB legislation has yet to be finalized. Once it is a sizeable partnership will be signed.
Only a fool would think MNTA would burn through $400M while generating an additional $200M per year"
once Teva launches lovenox, company has said it will go in cash burn state. do u ever listen to cc?
like the hidden value in the company. Just don't like the way management is managing this. I wish we had an activist investor that can shake this management
can u imagine another biotech getting valued so low by the street...
350m in cash, market cap of 900m earnings of >250m (of course without teva lovenox), with a launch of another big drug, 2 new clinical drugs, and FOB work
transparency on pipeline goals and costs will make the market value this. but wheeler is standing in b/w